Delivery Order SPE2DE24D0013-SPE2D625F3NKE

The Defense Logistics Agency's Medical Supply Chain division awarded a $7,480 firm fixed-price delivery order to Cepheid Inc. on September 16, 2025, with an ultimate completion date of September 30, 2025. This delivery order, designated XPCOV2/FLU/RSV-10, procures molecular diagnostic testing solutions for COVID-19, influenza, and respiratory syncytial virus (RSV) detection. The award carries no set-aside designation and represents a continuation of Cepheid's longstanding role as a primary supplier of advanced diagnostic systems and test kits to federal healthcare agencies. Cepheid, a for-profit molecular diagnostics manufacturer headquartered in Sunnyvale, California, specializes in GeneXpert diagnostic systems and associated reagents used across multiple federal health networks.

This delivery order likely derives from one of Cepheid's existing Indefinite Delivery Vehicle contracts with the Veterans Health Administration, which provide the framework for continuous procurement of molecular diagnostic solutions. Cepheid holds two significant VA IDV contracts—a $32.8 million single-award vehicle with Veterans Integrated Service Network 6 and a $2.5 million contract with Veterans Integrated Service Network 21—both structured as firm fixed-price delivery order vehicles that support laboratory microbiology and infectious disease testing across the federal healthcare system. The modest ceiling value of this particular delivery order reflects a routine procurement of diagnostic reagents or testing services aligned with the agency's ongoing COVID-19, influenza, and RSV surveillance and treatment capabilities.